TLR2 inhibition reprograms the tumor microenvironment and delays progression of recurrent ovarian cancer in vivo

被引：0
|
作者：
Alvero, A. [1 ]
Pitruzzello, M. [1 ]
Keogh, B. [2 ]
Mcguirk, P. [2 ]
Reilly, M. [2 ]
Mor, G. [1 ]
机构：
[1] Yale Univ, Ob Gyn, New Haven, CT USA
[2] Opsona Therapeut Ltd, Vivo Pharmacol, Dublin, Ireland
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
320 (PB-08
引用
收藏
页码：E107 / E107
页数：1
相关论文
共 50 条
  • [31] High Expression of TLR2 in the serum of patients with tuberculosis and lung cancer, and can promote the progression of lung cancer
    Zhang, Ming
    Zhou, Yingying
    Zhang, Yanli
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2020, 17 (03) : 1959 - 1972
  • [32] Modulation of the tumor microenvironment by the TLR9 agonist EnanDIM and combination with checkpoint inhibition for cancer immunotherapy
    Kapp, K.
    Volz, B.
    Oswald, D.
    Wittig, B.
    Schmidt, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] TLR9 Signaling Promotes Tumor Progression of Human Lung Cancer Cell In Vivo
    Ren, Tao
    Xu, Lin
    Jiao, Shuxian
    Wang, Yanying
    Cai, Yingyun
    Liang, Yongjie
    Zhou, Ya
    Zhou, Hong
    Wen, Zhenke
    PATHOLOGY & ONCOLOGY RESEARCH, 2009, 15 (04) : 623 - 630
  • [34] The interaction of HspA1A with TLR2 and TLR4 in the response of neutrophils induced by ovarian cancer cells in vitro
    Magdalena Klink
    Marek Nowak
    Michał Kielbik
    Katarzyna Bednarska
    Edyta Blus
    Marian Szpakowski
    Krzysztof Szyllo
    Zofia Sulowska
    Cell Stress and Chaperones, 2012, 17 : 661 - 674
  • [35] The interaction of HspA1A with TLR2 and TLR4 in the response of neutrophils induced by ovarian cancer cells in vitro
    Klink, Magdalena
    Nowak, Marek
    Kielbik, Michal
    Bednarska, Katarzyna
    Blus, Edyta
    Szpakowski, Marian
    Szyllo, Krzysztof
    Sulowska, Zofia
    CELL STRESS & CHAPERONES, 2012, 17 (06): : 661 - 674
  • [36] ME-344 delays tumor kinetics in an ovarian cancer in vivo recurrence model.
    Alvero, Ayesha B.
    Sumi, Natalia
    Craveiro, Vinicius
    Joo, Won Duk
    Yang-Hartwich, Yang
    Mor, Gil
    CANCER RESEARCH, 2013, 73 (08)
  • [37] Targeting the tumor microenvironment: inhibition of carbonic anhydrase 9 impedes brain tumor initiating cell chemoresistance and delays glioblastoma growth in vivo
    Boyd, Nathaniel H.
    Walker, Kiera
    McDonald, Paul C.
    Bevensee, Mark O.
    Gillespie, Yancey G.
    Nabors, Burt
    Dedhar, Shoukat
    Hjelmeland, Anita B.
    CANCER RESEARCH, 2017, 77
  • [38] Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers
    Bhatia, Shilpa
    Oweida, Ayman
    Lennon, Shelby
    Darragh, Laurel B.
    Milner, Dallin
    Phan, Andy V.
    Mueller, Adam C.
    Van Court, Benjamin
    Raben, David
    Serkova, Natalie J.
    Wang, Xiao-Jing
    Jimeno, Antonio
    Clambey, Eric T.
    Pasquale, Elena B.
    Karam, Sana D.
    CANCER RESEARCH, 2019, 79 (10) : 2722 - 2735
  • [39] Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
    Shen, Kuan-Yin
    Liu, Hsin-Yu
    Yan, Wan-Lun
    Wu, Chiao-Chieh
    Lee, Ming-Hui
    Leng, Chih-Hsing
    Liu, Shih-Jen
    CANCERS, 2020, 12 (04)
  • [40] Regulatory mechanisms of tumor microenvironment and progression of ovarian cancer peritoneal dissemination, which is induced by intraperitoneal transformation of tumor cells
    Kawata, Akira
    Taguchi, Ayumi
    Ogishima, Juri
    Yoshida, Mitsuyo
    Nakamura, Hiroe
    Aotsuka, Aeri
    Sato, Masakazu
    Eguchi, Satoko
    Tomio, Kensuke
    Adachi, Katsuyuki
    Oda, Katsutoshi
    Kawana, Kei
    Osuga, Yutaka
    Fujii, Tomoyuki
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2017, 124 : 71 - 71
12345